Volitionrx (VNRX) EBT Growth (3y) (2021 - 2025)
Volitionrx (VNRX) EBT Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 4.82% |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | 61.06% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -2.57% |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 32.11% |
| 10 | Volitionrx | 90,913.24 | -1.03 Mn | - | 40.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.43% |
| Sep 30, 2025 | -34.87% |
| Jun 30, 2025 | -28.57% |
| Mar 31, 2025 | -317.34% |
| Dec 31, 2024 | 91.89% |
| Sep 30, 2024 | -44.93% |
| Jun 30, 2024 | 16.22% |
| Mar 31, 2024 | -879.90% |
| Dec 31, 2023 | -618.94% |
| Sep 30, 2023 | -946.00% |
| Jun 30, 2023 | -1,105.14% |
| Mar 31, 2023 | -18.43% |
| Dec 31, 2022 | 26.52% |
| Sep 30, 2022 | 26.33% |
| Jun 30, 2022 | 26.40% |
| Mar 31, 2022 | 26.42% |
| Dec 31, 2021 | 26.37% |
| Sep 30, 2021 | 26.20% |
| Jun 30, 2021 | 26.21% |